Cancer immunotherapy: significant breakthrough or unrealised potential

This event has ended.

Cancer immunotherapy is a significant medical breakthrough that uses white blood cells - termed T cells - to prevent, control and eliminate cancer. Immunotherapy works miraculously well for some patients (15-20%), but most patients don’t respond, making a pressing need to unlock the promise of T cell therapy.

Prof Awen Gallimore will give an overview of Cardiff immunotherapy research, sharing fundamental discoveries in the lab taken through to plans for early phase trials in patients. Lorenzo Capitani, a PhD student at the School of Medicine, is investigating ways of taking the brakes off the immune system, in order to help T cells fight cancer more effectively.